Events
20.10.2009 - 22.10.2009
Fermenco attends EuropaBio's 2nd Annual European Forum for Industrial Biotechnology in Lisbon, Portugal.
16.04.2009 - 17.04.2009
Fermenco attends the conference: "Applied Industrial Synthetic Biology in Europe - Status Quo and Perspectives" in Heidelberg, Germany. Fermenco's technology will be presented in the talk: "Synthetic promoter libraries and recombineering techniques for transcriptional fine-tuning".
27.04.2008 - 30.04.2008
The 5th World Congress on Industrial Biotechnology and Bioprocesses, Chicago, Illinois.
09.03.2008 - 11.03.2008
VAAM/GBM meeting in Frankfurt, Germany: A collaboration project between GeneBridges and Fermenco for easy modulation of gene expression in
Escherichia co
li will be presented at the poster "The combined use of SPL and Red/ET
® technologies enables rapid fine tuning of
E. coli gene expression".
16.09.2007 - 19.09.2007
Fermenco ApS attends the 13th European Congress on Biotechnology, September 16-19 2007, Barcelona, Spain.
21.03.2007 - 24.03.2007
Fermenco ApS attends the World Congress on Industrial Biotechnology and Bioprocessing, March 21-24 2007, Orlando, Florida, USA with a poster presentation of the SPL and ATPase technologies. Title of the poster: "Two generic technologies for improving yield and production rate in microbial bioreactors".
July 2009
Fermenco requires commercial rights for a new technology: "Method of improving biomass yield of lactic acid bacterial cultures"". US2004214305/EP1301588
September 2008
Fermenco and GeneBridges GmbH publish the paper: "
Escherichia coli strains with promoter libraries constructed by Red/ET recombination pave the way for transcriptional fine-tuning" in
Biotechniques
45 (3).
April 2008
Fermenco granted European patent for the ATPase technology.
April 2007
Fermenco granted US patent for the ATPase technology.
12.12.2006
The new biotechnological company Fermenco ApS is founded by Professor Peter Ruhdal Jensen and Associate Professor Brian Koebmann as a spin-out from BioCentrum-DTU, Technical University of Denmark. Fermenco will work to commercialise patent protected technologies for genetic engineering in order to optimise industrial microorganisms for fermentation purposes.